Astellas Pharma Inc. - Liabilities and Stockholders Equity
Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.
The item "Liabilities-and-Stockholders-Equity" stands at 3.34 Trillion Japanese Yens as of 06/30/2025, the lowest value since 09/30/2023.
As of the end of Astellas Pharma Inc.'s first quarter, the item "Liabilities and Stockholders Equity" stands at 3.34 Trillion JPY. This represents a decrease of -0.11 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -10.70 percent compared to the value the year prior.
The 1 year change in percent is -10.70.
The 3 year change in percent is 34.41.
The 5 year change in percent is 47.86.
The 10 year change in percent is 87.41.
The Serie's change in percent from it's minimum value, on 12/31/2010, to it's latest available value, on 06/30/2025, is +156.15%.
The Serie's change in percent from it's maximum value, on 06/30/2024, to it's latest available value, on 06/30/2025, is -10.70%.
Liabilities and Stockholders Equity for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Liabilities and Stockholders Equity | 905,699,262,464.00 |
 | Johnson & Johnson - Liabilities and Stockholders Equity | 486,508,953,600.00 |
 | AbbVie Inc - Liabilities and Stockholders Equity | 399,570,305,024.00 |
 | Roche Holding AG - Liabilities and Stockholders Equity | 317,433,206,677.55 |
 | AstraZeneca PLC - Liabilities and Stockholders Equity | 280,205,508,085.11 |